Skip to main content

Table 3 Risk factors predicting non- Candida fungaemia

From: Clinical characteristics and risk factors of non-Candida fungaemia

Variables Univariate analysis Multivariate analysis
  Crude OR (95% CI) Pvalue Adjusted OR (95% CI) Pvalue
Co-morbidities
  Solid malignancy 0.55 (0.46-0.65) < 0.01 - -
  Chronic kidney disease 5.40 (1.48-19.7) 0.01 - -
  Collagen disease 3.75 (0.84-16.7) 0.09 9.00 (1.58-51.4) 0.01
Underlying conditions
  Prior bacteraemia 3.66 (1.00-13.4) 0.04   
  Colonisation by causative yeasts 3.77 (0.94-15.1) 0.05 - -
  Renal replacement therapy 8.33 (2.12-32.8) < 0.01 15.0 (3.06-73.4) < 0.01
Corticosteroid therapy 3.84 (1.05-14.1) 0.04 - -
  Chemotherapy 0.73 (0.65-0.82) 0.04 - -
  Other immunosuppressant therapy 4.27 (0.94-19.3) 0.08   
SOFA score a 1.13 (1.03-1.26) 0.02 - -
  1. OR: odds ratio; SOFA: sequential organ failure assessment.
  2. P values are marked in bold if < 0.05.
  3. a Variables categorised as an ordinal scale in 1-point increments: OR > 1 is the increase in likelihood of the outcome with a 1-point increase in the factor.
  4. P < 0.10, variable was included in the multivariate analysis of outcomes from non-Candida fungaemia versus candidaemia.